Serum Uromodulin and All-Cause Mortality in Peritoneal Dialysis Patients: A Chinese Cohort Study

Dominik Steubl; Li Fan; Yunfang Zhang; Fei Xiong; Hongbo Li; Hao Zhang; Jing Hu; Amy B. Karger; Lesley A. Inker; Xueqing Yu; Andrew S. Levey

doi:10.1016/j.xkme.2022.100536

Serum Uromodulin and All-Cause Mortality in Peritoneal Dialysis Patients: A Chinese Cohort Study

Dominik Steubl, Li Fan, Yunfang Zhang, Fei Xiong, Hongbo Li, Hao Zhang, Jing Hu, Amy B. Karger, Lesley A. Inker, Xueqing Yu, Andrew S. Levey

Laboratory Medicine and Pathology

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Article number	100536
Journal	Kidney Medicine
Volume	4
Issue number	10
DOIs	https://doi.org/10.1016/j.xkme.2022.100536
State	Published - Oct 2022

Bibliographical note

Funding Information:
Grant 2002B60118 from Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China; Operational grant 2017B030314019 of Guangdong Provincial Key Laboratory; Paul Teschan Research Fund – Dialysis Clinic Inc (“Monitoring PD Adequacy Using Serum Levels of Endogenous Filtration Marker”); and Driscoll Family Endowed Fund in Nephrology, Tufts Medical Center, Boston, Massachusetts.

Funding Information:
Research idea and study design: DS, LF, ASL; data acquisition: YZ, FX, HL, HZ, JH; sUMOD measurement: ABK; data analysis/interpretation: DS, LF, ASL, LAI, XY. DS and LF contributed equally to the manuscript. Each author contributed important intellectual content during manuscript drafting or revision and accepts accountability for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved. Grant 2002B60118 from Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China; Operational grant 2017B030314019 of Guangdong Provincial Key Laboratory; Paul Teschan Research Fund – Dialysis Clinic Inc (“Monitoring PD Adequacy Using Serum Levels of Endogenous Filtration Marker”); and Driscoll Family Endowed Fund in Nephrology, Tufts Medical Center, Boston, Massachusetts. The authors declare that they have no relevant financial interests. Received March 27, 2022 as a submission to the expedited consideration track with 2 external peer reviews. Direct editorial input from the Statistical Editor and an Associate Editor who served as Acting Editor-in-Chief. Accepted in revised form August 3, 2022. The involvement of an Acting Editor-in-Chief was to comply with Kidney Medicine's procedures for potential conflicts of interest for editors, described in the Information for Authors & Journal Policies.

PubMed: MeSH publication types

Journal Article

Publisher link

10.1016/j.xkme.2022.100536

Find It

Find It at U of M Libraries

Cite this

@article{83dfef9a330b404899734f72f85442bc,

title = "Serum Uromodulin and All-Cause Mortality in Peritoneal Dialysis Patients: A Chinese Cohort Study",

author = "Dominik Steubl and Li Fan and Yunfang Zhang and Fei Xiong and Hongbo Li and Hao Zhang and Jing Hu and Karger, {Amy B.} and Inker, {Lesley A.} and Xueqing Yu and Levey, {Andrew S.}",

note = "Funding Information: Grant 2002B60118 from Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China; Operational grant 2017B030314019 of Guangdong Provincial Key Laboratory; Paul Teschan Research Fund – Dialysis Clinic Inc (“Monitoring PD Adequacy Using Serum Levels of Endogenous Filtration Marker”); and Driscoll Family Endowed Fund in Nephrology, Tufts Medical Center, Boston, Massachusetts. Funding Information: Research idea and study design: DS, LF, ASL; data acquisition: YZ, FX, HL, HZ, JH; sUMOD measurement: ABK; data analysis/interpretation: DS, LF, ASL, LAI, XY. DS and LF contributed equally to the manuscript. Each author contributed important intellectual content during manuscript drafting or revision and accepts accountability for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved. Grant 2002B60118 from Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China; Operational grant 2017B030314019 of Guangdong Provincial Key Laboratory; Paul Teschan Research Fund – Dialysis Clinic Inc (“Monitoring PD Adequacy Using Serum Levels of Endogenous Filtration Marker”); and Driscoll Family Endowed Fund in Nephrology, Tufts Medical Center, Boston, Massachusetts. The authors declare that they have no relevant financial interests. Received March 27, 2022 as a submission to the expedited consideration track with 2 external peer reviews. Direct editorial input from the Statistical Editor and an Associate Editor who served as Acting Editor-in-Chief. Accepted in revised form August 3, 2022. The involvement of an Acting Editor-in-Chief was to comply with Kidney Medicine's procedures for potential conflicts of interest for editors, described in the Information for Authors & Journal Policies.",

year = "2022",

month = oct,

doi = "10.1016/j.xkme.2022.100536",

language = "English (US)",

volume = "4",

journal = "Kidney Medicine",

issn = "2590-0595",

publisher = "Elsevier Inc.",

number = "10",

}

TY - JOUR

T1 - Serum Uromodulin and All-Cause Mortality in Peritoneal Dialysis Patients

T2 - A Chinese Cohort Study

AU - Steubl, Dominik

AU - Fan, Li

AU - Zhang, Yunfang

AU - Xiong, Fei

AU - Li, Hongbo

AU - Zhang, Hao

AU - Hu, Jing

AU - Karger, Amy B.

AU - Inker, Lesley A.

AU - Yu, Xueqing

AU - Levey, Andrew S.

N1 - Funding Information: Grant 2002B60118 from Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China; Operational grant 2017B030314019 of Guangdong Provincial Key Laboratory; Paul Teschan Research Fund – Dialysis Clinic Inc (“Monitoring PD Adequacy Using Serum Levels of Endogenous Filtration Marker”); and Driscoll Family Endowed Fund in Nephrology, Tufts Medical Center, Boston, Massachusetts. Funding Information: Research idea and study design: DS, LF, ASL; data acquisition: YZ, FX, HL, HZ, JH; sUMOD measurement: ABK; data analysis/interpretation: DS, LF, ASL, LAI, XY. DS and LF contributed equally to the manuscript. Each author contributed important intellectual content during manuscript drafting or revision and accepts accountability for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved. Grant 2002B60118 from Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China; Operational grant 2017B030314019 of Guangdong Provincial Key Laboratory; Paul Teschan Research Fund – Dialysis Clinic Inc (“Monitoring PD Adequacy Using Serum Levels of Endogenous Filtration Marker”); and Driscoll Family Endowed Fund in Nephrology, Tufts Medical Center, Boston, Massachusetts. The authors declare that they have no relevant financial interests. Received March 27, 2022 as a submission to the expedited consideration track with 2 external peer reviews. Direct editorial input from the Statistical Editor and an Associate Editor who served as Acting Editor-in-Chief. Accepted in revised form August 3, 2022. The involvement of an Acting Editor-in-Chief was to comply with Kidney Medicine's procedures for potential conflicts of interest for editors, described in the Information for Authors & Journal Policies.

PY - 2022/10

Y1 - 2022/10

UR - http://www.scopus.com/inward/record.url?scp=85138825092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85138825092&partnerID=8YFLogxK

U2 - 10.1016/j.xkme.2022.100536

DO - 10.1016/j.xkme.2022.100536

M3 - Article

C2 - 36267675

AN - SCOPUS:85138825092

SN - 2590-0595

VL - 4

JO - Kidney Medicine

JF - Kidney Medicine

IS - 10

M1 - 100536

ER -

Serum Uromodulin and All-Cause Mortality in Peritoneal Dialysis Patients: A Chinese Cohort Study

Bibliographical note

PubMed: MeSH publication types

Publisher link

Find It

Other files and links

Cite this